In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer

@inproceedings{Torres2016InVA,
  title={In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer},
  author={Anna Torres and Joanna Kozak and Agnieszka Korolczuk and Paulina Wdowiak and Ewa Domańska-Glonek and Ryszard Maciejewski and K. de Souza Torres},
  booktitle={BMC Cancer},
  year={2016}
}
Endometrial cancer is the most common cancer of the female reproductive tract. Based on our previous studies we speculated that miR-92a exhibited pro-oncogenic properties in endometrial cancer, and therefore its inhibition could be used as a therapeutic measure in this disease. Therefore in the present study we aimed to investigate both in vitro and in vivo… CONTINUE READING